Release date: 2024-07-09 16:45:22 Recommended: 178

Cabometyx tablets are suitable for the treatment of advanced renal cell carcinoma (RCC) patients, and in combination with nivolumab, they are suitable for first-line treatment of advanced RCC patients; Suitable for treating hepatocellular carcinoma (HCC) patients who have previously received sorafenib treatment; Suitable for treating adult and pediatric patients aged 12 and above with locally advanced or metastatic differentiated thyroid cancer (DTC), who have progressed after previous VEGFR targeted therapy and are refractory or unqualified to radioactive iodine.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended:477Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended:475Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended:535Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended:414Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended:615Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended:401Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:570Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:482Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended:261Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended:267Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended:276Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended:257Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended:302Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended:262Release date: 2025-12-01